(Q51467422)

5 April 2018

title

Hyperhomocysteinemia and central retinal vein occlusion in Iranian population. (English)

1 reference

5 April 2018

central retinal vein occlusion

main subject

1 reference

Sasan Moghimi

1

1 reference

5 April 2018

Zahra Najmi

2

1 reference

5 April 2018

Hooshang Faghihi

3

1 reference

5 April 2018

Reza Karkhaneh

4

1 reference

5 April 2018

Mohammad Sadegh Farahvash

5

1 reference

5 April 2018

Maryam Maghsoudipour

6

1 reference

5 April 2018

publication date

17 July 2007

1 reference

5 April 2018

International Ophthalmology

published in

1 reference

5 April 2018

volume

28

1 reference

5 April 2018

issue

1

1 reference

5 April 2018

page(s)

23-28

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s10792-007-9103-4

exact match

0 references

cites work

Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10792-007-9103-4

Plasma total homocysteine and retinal vascular disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10792-007-9103-4

Does lowering plasma homocysteine reduce vascular disease risk?

21 January 2018

1 reference

12 December 2020

Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion

1 reference

12 December 2020

Homocysteine and hemostatic disorder as a risk factor for myocardial infarction at a young age.

1 reference

12 December 2020

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

12 December 2020

Thermolabile MTHFR genotype and retinal vascular occlusive disease

1 reference

12 December 2020

Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population

1 reference

12 December 2020

Hyperhomocysteinemia: a risk factor for central retinal vein occlusion

1 reference

12 December 2020

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

1 reference

12 December 2020

Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion

1 reference

12 December 2020

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

12 December 2020

Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion.

1 reference

12 December 2020

Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype

1 reference

12 December 2020

The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

1 reference

12 December 2020

Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion

1 reference

12 December 2020

Homocysteine: a risk factor for retinal venous occlusive disease

1 reference

12 December 2020

Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

1 reference

12 December 2020

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

12 December 2020

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion

1 reference

12 December 2020

Nine year follow-up study of morbidity and mortality in retinal vein occlusion

1 reference

12 December 2020

Homocysteine and cardiovascular disease

1 reference

12 December 2020

Plasma homocysteine and cysteine levels in retinal vein occlusion.

1 reference

12 December 2020

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion

1 reference

12 December 2020

Homocysteine and retinal vein occlusion: a population-based study

1 reference

12 December 2020

Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts

1 reference

12 December 2020

Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke

1 reference

12 December 2020

Homocysteine level in patients with established transmural myocardial infarction.

1 reference

12 December 2020

Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

1 reference

12 December 2020

Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.

1 reference

12 December 2020

Hyperhomocysteinaemia and vascular disease

1 reference

12 December 2020

Plasma homocysteine and cardiovascular disease mortality

1 reference

12 December 2020

Hyperhomocysteinemia: a risk factor for retinal vein occlusion

1 reference

12 December 2020

Hyperhomocysteinemia and retinal vascular occlusive disease

1 reference

12 December 2020

Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion

1 reference

12 December 2020

10.1007/S10792-007-9103-4

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17636432

1 reference

5 April 2018